SOLARA.NS

Solara Active Pharma Sciences Limited · Healthcare · Drug Manufacturers-Specialty & Generic

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$12.74B

PE Ratio

-56.14136179551122

EV to Ebitda

—

Earnings Yield

-147360166.28%

Revenue (TTM)

$172.1M

Net Income (TTM)

$-2.9M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

293.40%

Profit Margin

-1.69%

Return on Equity

—

Debt to Equity Ratio

—

Dividend Yield

0.00%

All fundamentals

Core6 fields›

Market Cap$12.74B

Revenue TTM$172.1M

Shares Outstanding36.0M

Float14744984

Insider Ownership59.92%

Institutional Ownership19.41%

Growth Estimates5 fields›

Revenue Growth (Quarterly YoY)293.40%

Rev Growth Est 1Y Forward0.1400

EPS Growth (Quarterly YoY)-96.50%

EPS Growth Est Quarterly-1

LT EPS Growth Estimates282.10%

Operations14 fields›

Revenue TTM$172.1M

Gross Margin TTM39.36%

Gross Margin (Quarterly)46.45%

Operating Margin TTM-0.53%

Operating Margin (Quarterly)4.31%

Profit Margin TTM-1.69%

Profit Margin (Quarterly)0.11%

Net Income TTM$-2.9M

EPS TTM-16.18

EBIT Margin TTM7.01%

EBITDA TTM$12.1M

Capex % of Revenue TTM17.45%

Capital Expenditures$30.0M

FCF % of Revenue (Quarterly)-31.65%

Efficiency1 fields›

ROA-3.16%

Valuation6 fields›

P/E (TTM)-56.14136179551122

P/E Forward0

EV/Revenues (TTM)2.3269

Earnings Yield-147360166.28%

Dividend Yield0.00%

Payout Ratio0.00%

Liquidity3 fields›

Cash Per Share16.548246736865273

Current Ratio1.157199816981502

Interest Expense$895.7M

Yields3 fields›

Dividend Yield0.00%

Payout Ratio0.00%

Earnings Yield-147360166.28%